Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
Academic rigor, journalistic flair
Articles on Pharmaceutical marketing
Displaying all articles
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
Evidence shows that opioid manufacturers fund patient advocacy groups in Canada, distorting policies to protect public health.
This week’s annual Family Medicine Forum is an opportunity for your family doctor – to cave or resist in the face of Big Pharma sponsorship and marketing.
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Assistant Professor, Bond University
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Lecturer in Family Medicine, Faculty of Medicine, L’Université d’Ottawa/University of Ottawa
-
Visiting Fellow in the Harvard Department of the History of Science, University of British Columbia
